-
Preventing Stunting Through Early Nutritional Intervention: Effectiveness and Economic Evaluation in Children With Weight Faltering
Sep 9, 2025, 16:22 PM -
Synthesizing Health Service Utilization Data for a Complex Intervention: A Case Study of Teledermatology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Sep 9, 2025, 16:22 PM -
Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Burden of Disease and Healthcare Resource Use in Patients With Hereditary Transthyretin Amyloidosis in Spain: Findings From the OverTTuRe Global Study
Sep 9, 2025, 16:22 PM -
Integrated Sustainability Assessment of the Population-Based Colorectal Cancer Screening Program in Flanders
Sep 9, 2025, 16:22 PM -
Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective
Sep 9, 2025, 16:22 PM -
Overfitting Mitigation in Neural Networks: Could Ergodic Regularization Be the Future of AI?
Sep 9, 2025, 16:22 PM -
Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation
Sep 9, 2025, 16:22 PM -
Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Out-of-Work Transitions in the European Population With Noncommunicable Diseases
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Lung Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Registration and Access to Orphan Medicines in Türkiye: A Comparative Study With Poland and Germany
Sep 9, 2025, 16:22 PM -
Overall Survival Adjusted for Subsequent Treatments: A Review of Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Conceptualizing an Economic Model Structure for Parkinson's Disease
Sep 9, 2025, 16:22 PM -
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal
Sep 9, 2025, 16:22 PM -
Patient-Reported Stigma Across Health Conditions: Insights From the National Health and Wellness Survey (NHWS) in China
Sep 9, 2025, 16:22 PM
